Sleep study at home

Terms and Conditions

I understand that the cervical cancer screening service is intended for asymptomatic clients, and I confirm that I have none the following symptoms: irregular bleeding, post-sexual intercourse bleeding, vaginal discharge, itching, lesions on the genital organs.

I commit to informing Biron if I develop one or more of the symptoms listed above during the process.

I understand that the service is intended for clients aged between 25 and 65 targeted by a collective prescription, and that anyone outside this age limit may be denied screening and redirected for a medical consultation during the assessment with the healthcare professional.

I understand that cervical cancer screening is generally recommended every 3 to 5 years. I understand that if my last screening is too recent, the healthcare professional may refuse to issue a screening prescription during the assessment. In such cases, only consultation fees will be charged. (Please note that individuals who have previously received a positive result for HPV or cytology may still be accepted.)

Choice of service provider

I understand that during my appointment, I may choose to have the sample collection and analysis done by a public services provider, whose services may be free, or by Biron Health Group or another service provider and bear the associated costs.

I understand that if I choose a services provider other than Biron Health Group, I will receive my prescription, and only Biron Health Group consultation fees will be charge. In which case, it will be my responsibility to find a services provider for sample collection and analysis and bear the associated costs.

Tests results

I understand that if I chose to retain the services of Biron Health Group, I will receive my results within 72 hours. I also understand that Biron Health Group is not responsible for the transmission delay of results by another services provider.

I understand that in case of a positive result requiring follow-up colposcopy, a consultation request will be sent to my region’s Service Request Distribution Center (SRDC), and Biron Health Group is not responsible for any delays.

STI screening

I understand that during my appointment, a healthcare professional will offer me the opportunity to assess my risk factors for contracting an STI, and I will have the option to undergo STI testing during my appointment (applicable fees apply).

Teleconsultation

I understand that healthcare professionals from Biron Health Group are authorized to provide consultation only to individuals located in the province of Quebec. I confirm that I am currently located in Quebec.

Terms and Conditions

STI screening service without prescription at Biron Medical Laboratory Inc. (Biron)

Before continuing, please read carefully and agree to the following terms and conditions.

I consent to a nurse contacting me by teleconsultation or phone to complete my assessment and inform me of positive results.

I agree to visit Biron’s STI page before my appointment, in order to learn important information about the STIs I am being screened for, including window periods and the advantages and disadvantages of screening. I understand that I should share any questions I may have at my testing appointment.

I understand that the screening service without a prescription is intended for asymptomatic clients and I confirm that I have no symptoms of any STI (unusual vaginal discharge, discharge from the penis, lesion/rash on genitals, abdominal or pelvic pain, pain in the genitals, jaundice, unusual and debilitating fatigue, fever, urinary or menstrual problems, unusual joint pain, any other symptoms that seem unusual to you). I agree to inform Biron if I develop any symptoms during the process.

Teleconsultation

I understand that the STI teleconsultation service is intended for clients without symptoms. Our healthcare professionals are only authorized to provide consultations to people located in the province of Quebec. I confirm that I am currently located in Quebec.

Reportable diseases

Certain infections, including STIs, must by law be reported to public health authorities. As such, if the result of this screening is positive, certain information will be sent to public health authorities.

In the event of a positive result

In the event of a positive result, I understand and agree that the medical team at Biron will provide a follow-up with me (at no additional cost) by teleconsultation.

I understand that the nurse in charge of the STI screening follow-up is available for any questions by phone or virtual consultation from Monday to Saturday, and that if a consultation with a doctor is deemed necessary, an appointment will be offered during business days only.

I give my consent for the STI screening service without a prescription. I may withdraw my consent at any time by notifying the nursing staff at Biron.

Conditions – Urinary tract infections and unusual vaginal discharge

Biron Health Group’s (Biron) service for treating urinary tract infections and unusual vaginal discharge (vaginitis and vaginosis) is intended for female clients aged 14 and over covered by a collective prescription and experiencing unusual vaginal discharge or urinary tract infection symptoms. Client may not have had or have any serious symptoms such as fever, intense pain, vomiting, etc. All such symptoms must be reported to Biron.

Anybody who is under the age of 14 or has one or more of the symptoms listed above may be refused treatment and referred for a medical consultation during the assessment with a healthcare professional.

Anybody who does not answer questions honestly or who has one or more symptoms likely to exclude them from the collective prescription will need to pay consultation fees and will be excluded from the program.

Fees of $95 for a consultation with a nurse are payable to Biron and will not be reimbursed by the Quebec Health Insurance Plan (Régie de l’assurance maladie du Québec, RAMQ).

At the clinic visit, patients may choose to make use of sampling and testing services offered by a public healthcare network provider (these services may be provided free of charge) or by a private sector provider, like Biron (and pay the costs). Patients opting for a provider other than Biron must make the necessary arrangements for organizing the sampling and testing and cover any costs. In that case, they will get their prescription and pay Biron only the $95 for a consultation with a nurse. Even so, the results will be forwarded to Biron for interpretation and for an appropriate drug prescription to be issued, as needed.

Anybody who chooses to use Biron’s services will receive their results within 72 hours. However, Biron is not responsible for delayed results being forwarded by another service provider. When test results are positive, a nurse will contact the client by phone to inform them and explain treatment.

During the clinic visit, a healthcare professional may offer clients the option of assessing the risk factors for a BBSTI and the option of taking BBSTI samples at the appointment (applicable charges are extra).

Some BBSTIs are notifiable diseases which have to be reported to Public Health. As a result, if the test result indicates a notifiable disease, Biron is required to report it and send the Public Health authorities specific information, including:

• The name of the notifiable disease
• For some BBSTIs, the name of the person and their sex, date of birth, address and postal code, phone number and health insurance number
• If applicable, the date the samples were taken for laboratory testing and the results obtained

Click here to learn more about notifiable diseases.

Terms and Conditions

STI screening service without prescription at Biron Medical Laboratory Inc. (Biron)

Before continuing, please read carefully and agree to the following terms and conditions.

Teleconsultation

I understand that the STI teleconsultation service is intended for clients without symptoms.

Our healthcare professionals are only authorized to provide consultations to people located in the province of Quebec. I confirm that I am currently located in Quebec.

I understand that the teleconsultation is not covered by the Régie de l'assurance maladie du Québec (RAMQ) and this service does not allow me to obtain a prescription for sampling or analysis done elsewhere than at a Biron service centre.